Cargando…
Phase I and registry study of autologous bone marrow concentrate evaluated in PDE5 inhibitor refractory erectile dysfunction
BACKGROUND: Bone marrow mononuclear cells have been successfully utilized for numerous regenerative purposes. In the current study, patients suffering from erectile dysfunction (ED) unresponsive to phosphodiesterase 5 inhibitors were administered autologous bone marrow concentrate delivered intracav...
Autores principales: | Bieri, Mark, Said, Elias, Antonini, Gabrielle, Dickerson, Donald, Tuma, Jorge, Bartlett, Courtney E., Patel, Amit N., Gershman, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958721/ https://www.ncbi.nlm.nih.gov/pubmed/31937310 http://dx.doi.org/10.1186/s12967-019-02195-w |
Ejemplares similares
-
Meniscus Allograft Transplantation Augmented With Autologous Bone Marrow Aspirate Concentrate
por: Morgan, Courtney, et al.
Publicado: (2023) -
Intracavernosal injections in the diagnosis and treatment of PDE–5 resistant erectile dysfunction
por: Jakubczyk, Tomasz
Publicado: (2013) -
AB233. PDE5-Is for erectile dysfunction in patients with multiple sclerosis
por: Yang, Xingliang, et al.
Publicado: (2016) -
Dr. Bang-Ping Jiann: PDE5 inhibitors in erectile dysfunction
por: Gao, Lucine M.
Publicado: (2016) -
Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina
por: Tuma, Jorge, et al.
Publicado: (2011)